Recombinant Protein Expression Services
Methionine Aminopeptidase (MAP) Production
Scale and transfer diagnostic enzyme production through process definition, risk mapping, raw-material controls, comparability, analytical readiness, and documentation. Our E. coli-based expression framework is designed for methionine aminopeptidase as a model protein, supporting research institutions and biotech companies that need MAP for enzymatic studies or as a reagent.
What Is Methionine Aminopeptidase?
Methionine aminopeptidase (MAP) is a ubiquitous metalloprotease that catalyzes the hydrolytic cleavage of the N-terminal methionine from newly synthesized polypeptides. This co-translational processing step is essential for protein maturation in bacteria and eukaryotes, making MAP a critical enzyme for both basic research and applied biotechnology.
In chemical biology research, MAP is widely used for N-terminal processing of peptides and proteins, enabling studies of protein function, stability, and interactions. Because MAP is essential for growth of several bacterial pathogens, it also represents a validated target for antibacterial drug discovery. For research institutions and enzyme suppliers, access to consistent, well-characterized recombinant MAP is essential for enzymatic assays, substrate specificity profiling, and industrial applications.
N-Terminal Methionine Excision
MAP removes the initiator methionine from nascent polypeptides, a step required for proper protein maturation and function in most organisms.
- Co-translational processing of nascent chains
- Essential for growth in several bacterial pathogens
- Ubiquitous in prokaryotes and eukaryotes
Chemical Biology and Drug Discovery
MAP is a valuable tool for N-terminal processing studies and a potential therapeutic target for antibacterial development.
- Substrate specificity profiling of peptides
- Enzymatic assays for inhibitor screening
- Studies of protein N-terminal processing
Expression and Purification
Producing active, correctly processed MAP requires careful attention to expression conditions, metal cofactor availability, and purification strategy.
- Metal-dependent activity requires proper cofactor handling
- Expression conditions affect yield and activity
- Purification must preserve enzymatic function
Why MAP Production Matters
Researchers and enzyme suppliers face a common challenge: obtaining recombinant MAP that is consistently active, properly folded, and available in sufficient quantities. Expression in E. coli offers a well-established route, but success depends on upstream process development—selecting the right strain, induction strategy, and fermentation conditions.
Our service addresses this challenge through a systematic expression framework that evaluates performance directly for methionine aminopeptidase as a model protein. By focusing on upstream process development, we help clients establish a reproducible production platform that supports downstream purification and application needs.
| Challenge | Impact | Our Approach | Outcome |
|---|---|---|---|
| Low expression yield | Insufficient material for assays or reagent supply | Fermentation optimization and strain selection | Improved volumetric productivity |
| Inconsistent activity | Variable assay results and unreliable reagent performance | Process definition and controlled induction conditions | Reproducible enzyme quality |
| Scale-up failure | Process works at lab scale but fails at larger volumes | Scale-up planning with risk mapping | Smooth technology transfer |
| Documentation gaps | Difficulty transferring process to CMO or internal production | Comprehensive documentation package | Ready for tech transfer |
How Our Service Works
Our recombinant MAP production service follows a structured workflow that moves from initial process definition through scale-up readiness. Each step is designed to build confidence in the process and deliver the documentation needed for successful technology transfer.
Process Definition
We begin by defining the target product profile for your MAP—including activity requirements, purity expectations, and intended use. This informs the expression strategy and guides all downstream decisions.
Expression Development
Using E. coli as the expression host, we evaluate induction conditions, media composition, and fermentation parameters to establish a robust upstream process that supports high-yield recombinant protein production.
Risk Mapping and Controls
We identify critical process parameters and raw-material risks, then implement controls to ensure consistency. This includes defining acceptable ranges for key inputs and monitoring points.
Scale-Up and Comparability
We plan and execute scale-up studies to confirm that the process performs comparably at larger volumes. Analytical readiness is built in, with appropriate assays to demonstrate product consistency.
Documentation and Transfer
The final deliverable is a comprehensive documentation package that captures the process, controls, and analytical methods—ready to support technology transfer to your production site or CMO.
Service Features
Our MAP production service is designed to address the specific challenges of producing this metalloprotease in E. coli. We combine upstream process expertise with a focus on deliverables that support your downstream success.
E. coli Expression Platform
We use E. coli as the expression host, a well-characterized system for recombinant protein production that offers defined genetics and scalable fermentation.
- Established host for high-yield production
- Defined genetic background for reproducible results
- Scalable fermentation options
Upstream Development
Our service centers on upstream process development—fermentation optimization and scale-up—to establish a solid foundation for purification and application.
- Induction strategy optimization
- Media and feed development
- Fermentation parameter screening
Risk-Based Approach
We map process risks and implement raw-material controls to ensure consistency across batches and support successful technology transfer.
- Critical parameter identification
- Raw-material risk assessment
- Control strategy development
Deliverables and Documentation
A successful process development engagement produces more than just a protocol—it produces the documentation and data needed to transfer the process with confidence. Our deliverables are designed to support your internal production or external manufacturing arrangements.
| Deliverable | Description | Purpose | Value |
|---|---|---|---|
| Process description | Detailed upstream process narrative | Defines how MAP is produced | Foundation for tech transfer |
| Batch records | Step-by-step production instructions | Enables reproducible execution | Operational readiness |
| Risk assessment | Identified risks and mitigation strategies | Proactive problem prevention | Process robustness |
| Analytical methods | Assays for activity and quality | Confirms product consistency | Quality assurance |
| Comparability data | Scale-up performance comparison | Demonstrates process scalability | Scale-up confidence |
Applications and Use Cases
Recombinant MAP produced through our service supports a range of research and commercial applications. Understanding your intended use helps us tailor the process to deliver the right product characteristics.
Enzymatic Studies
MAP is commonly used to study N-terminal processing of peptides and proteins, including substrate specificity profiling and kinetic characterization.
- Substrate specificity determination
- Inhibitor screening assays
- Mechanistic studies
Commercial Enzyme Production
For enzyme suppliers, consistent MAP production supports catalog reagent supply with defined quality attributes.
- Reproducible batch quality
- Defined activity specifications
- Scalable production
Antibacterial Target Support
MAP is essential for growth of several bacterial pathogens, making it a target for antibacterial drug discovery programs.
- Assay development support
- Compound screening
- Mechanism of action studies
Technical Specifications
The table below summarizes the key technical aspects of our MAP production service. Specific parameters are confirmed during project scoping to match your product requirements.
| Parameter | Specification | Consideration | Notes |
|---|---|---|---|
| Expression host | Escherichia coli | Well-characterized system | Defined genetics |
| Process focus | Upstream development | Fermentation optimization | Scale-up readiness |
| Activity requirement | Project-defined | Depends on application | Confirmed during scoping |
| Purity target | Project-defined | Application-dependent | Confirmed during scoping |
| Documentation | Comprehensive package | Process, controls, analytics | Tech transfer ready |
Quality and Support
Quality is built into every stage of our MAP production service—from process definition through documentation. We focus on delivering a process that is robust, reproducible, and ready for transfer.
Process Consistency
Our risk-based approach identifies critical parameters and implements controls to ensure batch-to-batch consistency.
- Critical parameter monitoring
- Raw-material controls
- Defined acceptance criteria
Activity Verification
Appropriate analytical methods are included to confirm enzyme activity and product quality throughout development.
- Activity assays
- Purity assessment
- Comparability testing
Project Collaboration
Support arrangements are confirmed with customer service consultation to match your project needs.
- Scoping discussions
- Progress updates
- Documentation review
Comparison: Our Approach vs. Ad Hoc Expression
Producing recombinant MAP without a structured development framework can lead to inconsistent yields, scale-up failures, and documentation gaps. Our service provides a systematic path from process definition to transfer readiness.
FAQ
What is methionine aminopeptidase used for?
Methionine aminopeptidase (MAP) catalyzes the removal of N-terminal methionine from newly synthesized proteins, a critical step in protein maturation. In research, it is used for N-terminal processing studies, substrate specificity profiling, and as a target for antibacterial drug discovery. For enzyme suppliers, it serves as a reagent for various biochemical assays.
Why is MAP production in E. coli challenging?
MAP is a metalloprotease whose activity depends on proper metal cofactor incorporation. Expression conditions, induction strategy, and fermentation parameters all affect yield and activity. Without systematic upstream process development, batches can be inconsistent, and scale-up may fail due to uncharacterized process parameters.
What does the service deliver?
The service delivers a defined upstream process for MAP production in E. coli, including process description, batch records, risk assessment, analytical methods, and comparability data from scale-up studies. The documentation package is designed to support technology transfer to your production site or manufacturing partner.
How is enzyme activity ensured?
Analytical methods are included as part of the service to verify enzyme activity and product quality. The specific assays are confirmed during project scoping based on your intended application, ensuring the process delivers MAP with the characteristics you need.
Can the process be scaled up?
Scale-up planning is an integral part of our service. We conduct scale-up studies to confirm process comparability at larger volumes and document the results. This approach helps identify potential issues early and ensures the process is ready for transfer to larger-scale production.
References
- Turra RJ, Horiya S, Neralkar M. Systematic Profiling of Peptide Substrate Specificity in N-Terminal Processing by Methionine Aminopeptidase Using mRNA Display and an Unnatural Methionine Analogue. ACS Chem Biol 2026 Feb 20. View on PubMed
- Kuznetsov G, Yarovikova M, Buslaeva E. An expression framework for production of recombinant methionine aminopeptidase in Escherichia coli: a case study of upstream process. Protein Expr Purif 2026 Aug 26. View on PubMed
- Systematic profiling of peptide substrate specificity in N- .. by RJ Turra · 2025 · Cited by 1 — Methionine aminopeptidase (MAP) is useful in chemical biology research for N-terminal processing of peptides and proteins and in medicine as ... View on PubMed
- Systematic Profiling of Peptide Substrate Specificity in N .. by RJ Turra · 2026 · Cited by 1 — Methionine aminopeptidase (MAP) is useful in chemical biology research for the N-terminal processing of peptides and proteins and in medicine as a potential ... View article
- by TR Helgren · 2016 · Cited by 45 — Abstract. Advances in Bacterial Methionine Aminopeptidase Inhibition. Methionine aminopeptidases (MetAPs) are metalloenzymes that cleave the N-terminal methionine from newly synthesized peptides and proteins. View article
- Atanassova A, Sugita M, Sugiura M. Molecular cloning, expression and characterization of three distinctive genes encoding methionine aminopeptidases in cyanobacterium Synechocystis sp. strain PCC6803. Arch Microbiol 2003 Sep. View on PubMed
Ready to Develop Your MAP Production Process?
Contact us to discuss your methionine aminopeptidase production needs. Our team will work with you to scope a project that delivers the process definition, documentation, and scale-up readiness you need for successful production and transfer.